SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-017583
Filing Date
2023-05-11
Accepted
2023-05-11 16:24:12
Documents
52
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vyne-20230331.htm   iXBRL 10-Q 831155
2 EX-10.1 vyne-101tayagreement.htm EX-10.1 16083
3 EX-31.1 vyne-20230331xexx311.htm EX-31.1 9706
4 EX-31.2 vyne-20230331xexx312.htm EX-31.2 9700
5 EX-32.1 vyne-20230331xexx321.htm EX-32.1 5276
6 EX-32.2 vyne-20230331xexx322.htm EX-32.2 5271
12 image_0.jpg GRAPHIC 62304
13 image_1.jpg GRAPHIC 4835
  Complete submission text file 0001628280-23-017583.txt   4362420

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vyne-20230331.xsd EX-101.SCH 30723
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vyne-20230331_cal.xml EX-101.CAL 48849
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vyne-20230331_def.xml EX-101.DEF 170501
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vyne-20230331_lab.xml EX-101.LAB 399599
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vyne-20230331_pre.xml EX-101.PRE 271511
46 EXTRACTED XBRL INSTANCE DOCUMENT vyne-20230331_htm.xml XML 518040
Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38356 | Film No.: 23911423
SIC: 2834 Pharmaceutical Preparations